DEFA14A: PAVmed Inc. Amends 2014 Long-Term Incentive Equity Plan to Include Full Text

PAVmed Inc. supplements its proxy statement to include the full text of the amended 2014 Long-Term Incentive Equity Plan for the upcoming annual meeting.

Summary

• PAVmed Inc. has issued a supplement to its proxy statement for the annual meeting of stockholders to be held on June 18, 2025.
• The supplement includes the full text of the Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan, which was not included in the original proxy statement.
• The purpose of the plan is to enable the company to offer long-term incentives to employees, officers, directors, and consultants.
• The plan allows for the granting of stock options, stock appreciation rights, restricted stock, and other stock-based awards.
• The total number of shares of Common Stock reserved and available for issuance under the Plan is 4,912,140 shares, subject to adjustments.
• The number of shares available will automatically increase on January 1st of each year until January 1, 2031, by an amount equal to 5% of the total number of shares of Common Stock outstanding on December 31st of the preceding calendar year.
• The committee administering the plan has the authority to determine the terms and conditions of awards, including vesting schedules and performance goals.
• The plan includes provisions for adjustments in the event of changes in capitalization, such as stock splits or dividends.
• Awards may be granted to employees, officers, directors, and consultants who are deemed to have rendered or to be able to render significant services to the Company or its Subsidiaries.
• The plan also outlines terms and conditions for stock options, including exercise price, exercisability, and transferability.
• The plan includes provisions for accelerated vesting and exercisability in certain circumstances, such as unapproved transactions.
• The Board may amend, alter, suspend, or discontinue any of the provisions of the Plan, but no amendment shall impair the rights of a Holder under any Agreement theretofore entered into hereunder, without the Holders consent, except as set forth in this Plan.

Sentiment

Score: 7

Explanation: The document is a routine update regarding the company's equity incentive plan, which is generally viewed positively as it aligns employee interests with shareholder value. The sentiment is neutral to slightly positive.

Positives

• The plan provides a framework for attracting and retaining key personnel through long-term incentives.
• The automatic annual increase in shares available ensures the plan remains relevant as the company grows.
• The flexibility in award types allows the company to tailor incentives to individual circumstances and performance goals.
• The plan includes provisions for adjustments in the event of changes in capitalization, protecting the value of awards.
• The plan allows for accelerated vesting in certain circumstances, incentivizing key personnel to remain with the company during critical periods.

Negatives

• The plan includes provisions that allow the company to repurchase stock options at a price not to exceed the Repurchase Value, which could be viewed negatively by employees.
• The plan allows the committee to require a Holder of any award granted under this Plan to relinquish such award to the Company upon the tender by the Company to Holder of cash in an amount equal to the Repurchase Value of such award.

Risks

• The plan's effectiveness depends on the committee's ability to administer it fairly and consistently.
• Changes in tax laws or accounting regulations could impact the value and attractiveness of the awards.
• The plan's success relies on the company's ability to achieve its performance goals, which may be subject to market conditions and other external factors.
• The potential for dilution of existing shareholders' equity due to the issuance of new shares under the plan.
• The plan includes provisions that allow the company to require such Holder to return to the Company the economic value of any award that was realized or obtained by such Holder at any time during the period beginning on that date that is six months prior to the date such Holders employment with the Company is terminated.

Future Outlook

The plan is designed to provide long-term incentives to key personnel, aligning their interests with the company's success and promoting future growth.

Management Comments

• The purpose of the PAVmed Inc. 2014 Long-Term Incentive Equity Plan (Plan) is to enable the Company to offer to its employees, officers, directors and consultants whose past, present and/or potential future contributions to the Company and its Subsidiaries have been, are or will be important to the success of the Company, an opportunity to acquire a proprietary interest in the Company.
• The various types of long-term incentive awards that may be provided under the Plan will enable the Company to respond to changes in compensation practices, tax laws, accounting regulations and the size and diversity of its businesses.

Industry Context

Long-term incentive plans are a common practice in the industry to attract, retain, and motivate key employees and align their interests with those of the shareholders.

Comparison to Industry Standards

• Many companies in the biotechnology and medical device industries utilize equity-based compensation plans to incentivize employees.
• The specific terms of PAVmed's plan, such as the number of shares reserved and the vesting schedules, would need to be compared to those of similar-sized companies in the industry to assess its competitiveness.
• Companies like Medtronic, Boston Scientific, and Stryker also use a mix of stock options, restricted stock, and performance-based awards in their compensation packages.
• The annual increase of 5% in shares available is a fairly standard practice to account for company growth and employee promotions.

Stakeholder Impact

• Shareholders: The plan could dilute existing shareholders' equity but also incentivizes management to increase shareholder value.
• Employees: The plan provides employees with the opportunity to acquire a proprietary interest in the company, aligning their interests with the company's success.
• Management: The plan provides management with long-term incentives to drive company performance.

Next Steps

• Stockholders will vote on the amended 2014 Long-Term Incentive Equity Plan at the annual meeting on June 18, 2025.

Key Dates

Keywords

incentive equity plan, stock options, restricted stock, stock appreciation rights, equity compensation, PAVmed, awards, shares